Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis

ISSN： 1746-0875

Source： Future Lipidology, Vol.3, Iss.6, 2008-12, pp. : 599-602

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective apheresis of C‐reactive protein: A new therapeutic option in myocardial infarction?

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 1, 2015-02 ,pp. : 15-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

C‐reactive protein and ageing

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 44, Iss. S1, 2017-12 ,pp. : 9-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

C-reactive protein and tumor necrosis factor-alpha in relation to insulin-mediated glucose uptake, smoking and atherosclerosis

By Fagerberg Bjorn Behre Carl Johan Wikstrand John Hulten Lillemor Mattsson Hulthe Johannes

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 68, Iss. 7, 2008-01 ,pp. : 534-541

Informa Healthcare

Access to resources Recommend Favorite

C-Reactive Protein in Dilated Cardiomyopathy

Cardiology, Vol. 91, Iss. 4, 1999-10 ,pp. : 215-219

Karger

Access to resources Recommend Favorite

Analysis of Trial Data for Infliximab and Golimumab: Baseline C‐Reactive Protein Level and Prediction of Therapeutic Response in Patients With Psoriatic Arthritis

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1114-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite